Ureteral Stents Market Size, Share, Growth Drivers, and Industry Outlook

The Ureteral Stents Market is evolving rapidly as healthcare providers increasingly prioritize minimally invasive procedures, improved patient comfort, and advanced urinary drainage solutions. Ureteral stents are widely used for managing ureteral obstruction caused by kidney stones, tumors, strictures, transplantation procedures, and other urological conditions. Improvements in stent materials and design are creating new opportunities for manufacturers.

Market Research Future reports that the global market reached USD 668.0 million in 2025 and is expected to grow from USD 711.8 million in 2026 to USD 1,259.9 million by 2035. The market is projected to register a CAGR of 6.55% during 2026–2035.

Material innovation is becoming increasingly important because conventional stents can cause complications such as encrustation, migration, discomfort, and infection. Polyurethane remains the leading material category, representing approximately 44.8% of segment revenue in the base year. Manufacturers are therefore investing in coatings, flexible polymers, radiopaque materials, and biodegradable technologies to improve device performance.

Biodegradable ureteral stents represent one of the most promising areas of innovation. Market Research Future indicates that biodegradable designs could expand at a 10.75% CAGR through 2035. These products are being developed to provide temporary drainage while naturally resorbing after the required healing period. Their potential to reduce follow-up removal procedures makes them attractive for both clinicians and patients.

The growing use of minimally invasive urological procedures is also strengthening market demand. Ureteral stents are frequently incorporated into treatment pathways involving stone removal and other endourological interventions. Kidney stone management accounted for approximately 56.8% of the market in 2025, highlighting the importance of nephrolithiasis treatment to overall device demand.

Hospitals remain the dominant end-user category, accounting for approximately 63.0% of end-user demand. However, ambulatory surgical centers are gaining importance as healthcare systems increasingly shift suitable procedures toward outpatient settings.

Geographically, North America held the leading position in 2025, while Asia-Pacific is projected to demonstrate the fastest growth. Expanding healthcare infrastructure, increasing medical expenditure, and greater awareness of advanced urological treatments are supporting regional demand.

As manufacturers continue developing anti-encrustation coatings, biodegradable materials, drug-eluting technologies, and patient-friendly designs, the Ureteral Stents Market is expected to remain an important growth area within the global medical devices industry.